AstraZeneca Pharma jumps after strong Q1 earnings

AstraZeneca Pharma India surged 5.93% to Rs 1,069.65 at 13:49 IST on BSE after net profit jumped 288.6% to Rs 10.57 crore on 15% growth in net sales to Rs 138.09 crore in Q1 June 2016 over Q1 June 2015.

The result was announced after market hours yesterday, 9 August 2016.

Meanwhile, the S&P BSE Sensex was down 268.65 points or 0.96% at 27,816.51.

On BSE, so far 36,000 shares were traded in the counter as against average daily volume of 1,356 shares in the past one quarter. The stock hit a high of Rs 1,122 and a low of Rs 1,049.70 so far during the day. The stock had hit a 52-week high of Rs 1,348 on 12 January 2016. The stock had hit a 52-week low of Rs 995.40 on 9 August 2016. The stock had underperformed the market over the past one month till 9 August 2016, sliding 4.91% compared with 3.53% rise in the Sensex. The scrip had also underperformed the market in past one quarter, declining 11.07% as against Sensex's 9.33% rise.

The small-cap company has equity capital of Rs 5 crore. Face value per share is Rs 2.

AstraZeneca Pharma India is present in seven crucial areas of healthcare - Cardiovascular, Diabetes, Oncology, Respiratory & Inflammation, Infection, Local Anesthesia and Maternal Healthcare.

Powered by Capital Market - Live News